RhumbLine Advisers’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.17M | Buy |
106,599
+8,333
| +8% | +$170K | ﹤0.01% | 1843 |
|
|
2025
Q1 | $1.78M | Buy |
98,266
+6,327
| +7% | +$115K | ﹤0.01% | 1866 |
|
|
2024
Q4 | $2.32M | Sell |
91,939
-650
| -0.7% | -$16.4K | ﹤0.01% | 1807 |
|
|
2024
Q3 | $3.15M | Sell |
92,589
-3,891
| -4% | -$132K | ﹤0.01% | 1656 |
|
|
2024
Q2 | $3.57M | Sell |
96,480
-2,050
| -2% | -$75.9K | ﹤0.01% | 1583 |
|
|
2024
Q1 | $4.14M | Buy |
98,530
+22,508
| +30% | +$945K | ﹤0.01% | 1512 |
|
|
2023
Q4 | $3.02M | Sell |
76,022
-652
| -0.9% | -$25.9K | ﹤0.01% | 1696 |
|
|
2023
Q3 | $2.11M | Buy |
76,674
+3,121
| +4% | +$85.9K | ﹤0.01% | 1826 |
|
|
2023
Q2 | $2.5M | Sell |
73,553
-371
| -0.5% | -$12.6K | ﹤0.01% | 1781 |
|
|
2023
Q1 | $2.66M | Buy |
73,924
+2,016
| +3% | +$72.5K | ﹤0.01% | 1664 |
|
|
2022
Q4 | $3.21M | Buy |
71,908
+1,533
| +2% | +$68.3K | ﹤0.01% | 1548 |
|
|
2022
Q3 | $1.98M | Buy |
70,375
+5,417
| +8% | +$152K | ﹤0.01% | 1767 |
|
|
2022
Q2 | $1.75M | Buy |
64,958
+12,739
| +24% | +$343K | ﹤0.01% | 1834 |
|
|
2022
Q1 | $1.78M | Buy |
52,219
+2,396
| +5% | +$81.6K | ﹤0.01% | 1879 |
|
|
2021
Q4 | $1.93M | Buy |
49,823
+558
| +1% | +$21.6K | ﹤0.01% | 1906 |
|
|
2021
Q3 | $2.66M | Buy |
49,265
+8,430
| +21% | +$455K | ﹤0.01% | 1733 |
|
|
2021
Q2 | $1.37M | Buy |
+40,835
| New | +$1.37M | ﹤0.01% | 2112 |
|
|
2018
Q2 | – | Sell |
-8,399
| Closed | -$294K | – | 2909 |
|
|
2018
Q1 | $294K | Buy |
8,399
+28
| +0.3% | +$980 | ﹤0.01% | 2443 |
|
|
2017
Q4 | $357K | Sell |
8,371
-1,537
| -16% | -$65.5K | ﹤0.01% | 2378 |
|
|
2017
Q3 | $425K | Buy |
9,908
+64
| +0.7% | +$2.75K | ﹤0.01% | 2391 |
|
|
2017
Q2 | $365K | Sell |
9,844
-303
| -3% | -$11.2K | ﹤0.01% | 2461 |
|
|
2017
Q1 | $549K | Buy |
10,147
+1,474
| +17% | +$79.8K | ﹤0.01% | 2200 |
|
|
2016
Q4 | $461K | Sell |
8,673
-1,201
| -12% | -$63.8K | ﹤0.01% | 2272 |
|
|
2016
Q3 | $598K | Buy |
9,874
+500
| +5% | +$30.3K | ﹤0.01% | 2094 |
|
|
2016
Q2 | $617K | Buy |
9,374
+1,338
| +17% | +$88.1K | ﹤0.01% | 2071 |
|
|
2016
Q1 | $456K | Buy |
8,036
+808
| +11% | +$45.9K | ﹤0.01% | 2284 |
|
|
2015
Q4 | $1.7M | Buy |
7,228
+340
| +5% | +$80K | 0.01% | 1458 |
|
|
2015
Q3 | $1.09M | Sell |
6,888
-236
| -3% | -$37.3K | ﹤0.01% | 1713 |
|
|
2015
Q2 | $2.7M | Buy |
7,124
+318
| +5% | +$120K | 0.01% | 1217 |
|
|
2015
Q1 | $2.85M | Buy |
6,806
+868
| +15% | +$363K | 0.01% | 1169 |
|
|
2014
Q4 | $1.63M | Buy |
5,938
+377
| +7% | +$103K | ﹤0.01% | 1494 |
|
|
2014
Q3 | $1.08M | Sell |
5,561
-470
| -8% | -$91.4K | ﹤0.01% | 1710 |
|
|
2014
Q2 | $1.48M | Sell |
6,031
-251
| -4% | -$61.4K | ﹤0.01% | 1571 |
|
|
2014
Q1 | $1.67M | Sell |
6,282
-73
| -1% | -$19.3K | ﹤0.01% | 1472 |
|
|
2013
Q4 | $2.31M | Buy |
6,355
+664
| +12% | +$241K | 0.01% | 1283 |
|
|
2013
Q3 | $3.03M | Buy |
5,691
+58
| +1% | +$30.8K | 0.01% | 1090 |
|
|
2013
Q2 | $1.32M | Buy |
+5,633
| New | +$1.32M | ﹤0.01% | 1574 |
|